Search in:

Journal of Drug Assessment Volume 8, 2019 - Issue 1

Journal homepage

Open access

1,521

Views

CrossRef citations to date

Altmetric

Oncology

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma

Maria LorenziPrecision Xtract, Oakland, CA, USA;

Stella ArndorferPrecision Xtract, Oakland, CA, USA;

Raquel Aguiar-IbañezMerck & Co., Inc, Kenilworth, NJ, USA

Emilie ScherrerMerck & Co., Inc, Kenilworth, NJ, USACorrespondence[email protected]

Frank Xiaoqing LiuMerck & Co., Inc, Kenilworth, NJ, USA

Clemens KreplerMerck & Co., Inc, Kenilworth, NJ, USA

Pages 135-145 | Received 22 Mar 2019, Accepted 10 Jul 2019, Published online: 15 Aug 2019

Cite this article
https://doi.org/10.1080/21556660.2019.1649266
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (8)

Lotte L. Hoeijmakers, Irene L.M. Reijers & Christian U. Blank. (2023) Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma. Cancer Discovery 13:11, pages 2319-2338.
Crossref

He Ba, Fangyuan Zhu, Xiaoze Zhang, Zubing Mei & Yaodong Zhu. (2023) Comparison of efficacy and tolerability of adjuvant therapy for resected high-risk stage III-IV cutaneous melanoma: a systemic review and Bayesian network meta-analysis. Therapeutic Advances in Medical Oncology 15, pages 175883592211489.
Crossref

Cassie Beisel, Tayla Poretta, Vanessa B. Sheppard, Alejandra Hurtado-de Mendoza, Heather Sipsma, Eleanore Fuqua, Brian Stwalley, Anthony Salvatore & Min Yang. (2022) Adherence to Adjuvant Therapy in Patients with Resected Melanoma: An Application of the Theory of Planned Behavior. Advances in Therapy 39:9, pages 4061-4075.
Crossref

Kabirraaj Toor, Mark R. Middleton, Keith Chan, Adenike Amadi, Andriy Moshyk & Srividya Kotapati. (2021) Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis. BMC Cancer 21:1.
Crossref

Jeffrey S. Weber, Paolo A. Ascierto, Mark R. Middleton, Delphine Hennicken, Roberto Zoffoli, Anne Pieters, Adenike Amadi, Katrin Kupas, Srividya Kotapati, Andriy Moshyk & Dirk Schadendorf. (2021) Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma. European Journal of Cancer 158, pages 225-233.
Crossref

Jingjing Li, Jiuhong Wang, Dandan Li, Xizhi Wen, Ya Ding, Xing Liu, Hang Jiang, Fuxue Huang & Xiaoshi Zhang. (2021) Adjuvant PD ‐1 inhibitor versus high‐dose interferon α‐2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis . Dermatologic Therapy 34:5.
Crossref

Arielle G. Bensimon, Zheng-Yi Zhou, Madeline Jenkins, Yan Song, Wei Gao, James Signorovitch, Clemens Krepler, Emilie Scherrer, Jingshu Wang & Raquel Aguiar-Ibáñez. (2020) An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA. Clinical Drug Investigation 40:7, pages 629-643.
Crossref

Minjeong Yeon, Youngmi Kim, Hyun Suk Jung & Dooil Jeoung. (2020) Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma. Frontiers in Cell and Developmental Biology 8.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma

Articles from other publishers (8)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma

Citations (8)

Articles from other publishers (8)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date